ArticleAmerican journal of translational research2019

Overexpression of Rad51 predicts poor prognosis and silencing of Rad51 increases chemo-sensitivity to doxorubicin in neuroblastoma.

Yonghu Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.